Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CASI Pharmaceuticals, Inc. - Ordinary Shares (NQ:CASI)

2.310 -0.130 (-5.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,865
Open 2.450
Bid (Size) 2.250 (4)
Ask (Size) 2.270 (8)
Prev. Close 2.440
Today's Range 2.280 - 2.450
52wk Range 1.091 - 7.670
Shares Outstanding 13,378,175
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
CASI Pharmaceuticals Announces Second Quarter 2025 Business and Financial Results
Via ACCESS Newswire

Performance

YTD
-22.5%
-22.5%
1 Month
+52.0%
+52.0%
3 Month
+22.9%
+22.9%
6 Month
-2.1%
-2.1%
1 Year
-63.8%
-63.8%

More News

Read More
CASI Pharmaceuticals to Participate at Cantor Global Healthcare Conference 2025
Via ACCESS Newswire
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Wondering what's happening in today's after-hours session?
Via Chartmill
Top movers in Friday's session
Via Chartmill
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Loop Industries (NASDAQ: LOOP) Ignites Paradigm Shift – Twist™ A Breakthrough in Circular Sustainability – More Stocks Inside
Via AB Newswire
Topics Economy
Top stock movements in today's session.
Via Chartmill
CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
Via ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer to Lead U.S. Company Focused on Clinical Development of CID-103, a Potential Best in Class Anti-CD38 Program
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
CASI Pharmaceuticals Provides Business and Clinical Update
Via ACCESS Newswire
CASI Pharmaceuticals Announces First Quarter 2025 Business and Financial Results
Via ACCESS Newswire
CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China
Via ACCESS Newswire
CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement
Via ACCESS Newswire
CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely Bullish
Via Stocktwits
CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company
Via ACCESS Newswire

Frequently Asked Questions

Is CASI Pharmaceuticals, Inc. - Ordinary Shares publicly traded?
Yes, CASI Pharmaceuticals, Inc. - Ordinary Shares is publicly traded.
What exchange does CASI Pharmaceuticals, Inc. - Ordinary Shares trade on?
CASI Pharmaceuticals, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CASI Pharmaceuticals, Inc. - Ordinary Shares?
The ticker symbol for CASI Pharmaceuticals, Inc. - Ordinary Shares is CASI on the Nasdaq Stock Market
What is the current price of CASI Pharmaceuticals, Inc. - Ordinary Shares?
The current price of CASI Pharmaceuticals, Inc. - Ordinary Shares is 2.310
When was CASI Pharmaceuticals, Inc. - Ordinary Shares last traded?
The last trade of CASI Pharmaceuticals, Inc. - Ordinary Shares was at 08/29/25 04:00 PM ET
What is the market capitalization of CASI Pharmaceuticals, Inc. - Ordinary Shares?
The market capitalization of CASI Pharmaceuticals, Inc. - Ordinary Shares is 30.90M
How many shares of CASI Pharmaceuticals, Inc. - Ordinary Shares are outstanding?
CASI Pharmaceuticals, Inc. - Ordinary Shares has 31M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.